Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MOHAMMADBAGHER ZIARI

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1962601047
CMS profile
271171
Location
CORONA, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$495,492.09

406 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $122,504.71 106
E.R. Squibb & Sons, L.L.C. $91,495.60 76
Regeneron Healthcare Solutions, Inc. $77,573.26 57
Karyopharm Therapeutics Inc. $68,143.15 39
GENZYME CORPORATION $34,024.00 22
Daiichi Sankyo Inc. $28,948.97 22
Lilly USA, LLC $24,881.44 20
SERVIER PHARMACEUTICALS LLC $24,462.06 34
Amgen Inc. $11,557.60 12
ABBVIE INC. $6,189.48 6
Incyte Corporation $2,320.00 2
Celgene Corporation $1,500.00 3
CTI BioPharma Corp. $675.00 1
Epizyme, Inc., $525.00 1
Alexion Pharmaceuticals, Inc. $250.00 1
Novocure GmbH $200.00 1
JAZZ PHARMACEUTICALS INC. $124.89 1
Medtronic, Inc. $100.63 1
Merck Sharp & Dohme LLC $16.30 1

Page 3 of 9; records 101–150 of 406 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MOHAMMADBAGHER ZIARI

NPI 1962601047 · CMS profile ID 271171

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

CORONA, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 9; records 101–150 of 406 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1962601047?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MOHAMMADBAGHER ZIARI, NPI 1962601047, CMS profile ID 271171. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 9; records 101–150 of 406 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1962601047?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). MOHAMMADBAGHER ZIARI, NPI 1962601047, CMS profile ID 271171. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 9; records 101–150 of 406 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1962601047?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
MOHAMMADBAGHER ZIARI, NPI 1962601047, CMS profile ID 271171, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 9; records 101–150 of 406 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1962601047?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

406 matching records · $495,492.09 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 406 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 406.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Daiichi Sankyo Inc. $550.0010/06/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930886755 CMS
AstraZeneca Pharmaceuticals LP $4,450.0010/02/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914745421 CMS
Karyopharm Therapeutics Inc. $4,075.0009/30/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946524427 CMS
Karyopharm Therapeutics Inc. $400.0009/30/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946524465 CMS
AstraZeneca Pharmaceuticals LP $585.1009/29/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914812413 CMS
AstraZeneca Pharmaceuticals LP $1,100.0009/29/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915211081 CMS
AstraZeneca Pharmaceuticals LP $24.4509/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915276051 CMS
AstraZeneca Pharmaceuticals LP $72.8709/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915823289 CMS
Lilly USA, LLC $120.0009/29/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918203193 CMS
AstraZeneca Pharmaceuticals LP $416.7009/28/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914816185 CMS
AstraZeneca Pharmaceuticals LP $594.7209/28/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915588133 CMS
AstraZeneca Pharmaceuticals LP $125.1609/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915669321 CMS
Karyopharm Therapeutics Inc. $4,075.0009/26/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946524421 CMS
Karyopharm Therapeutics Inc. $410.0009/26/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946524447 CMS
Karyopharm Therapeutics Inc. $17.1809/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946524453 CMS
Lilly USA, LLC $950.0009/23/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918243721 CMS
Lilly USA, LLC $2,500.0009/23/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918251907 CMS
AstraZeneca Pharmaceuticals LP $300.0009/22/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915792671 CMS
ABBVIE INC. $260.0009/21/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893269347 CMS
AstraZeneca Pharmaceuticals LP $4,450.0009/21/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915841483 CMS
AstraZeneca Pharmaceuticals LP $1,100.0009/20/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915665633 CMS
Regeneron Healthcare Solutions, Inc. $243.0009/20/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927488941 CMS
Regeneron Healthcare Solutions, Inc. $94.0009/20/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927488947 CMS
AstraZeneca Pharmaceuticals LP $300.0009/19/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915612001 CMS
Karyopharm Therapeutics Inc. $18.0509/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946524433 CMS
Karyopharm Therapeutics Inc. $4,075.0009/16/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946524439 CMS
Karyopharm Therapeutics Inc. $270.0009/16/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946524459 CMS
AstraZeneca Pharmaceuticals LP $124.9909/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914834779 CMS
AstraZeneca Pharmaceuticals LP $320.0009/15/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914851109 CMS
Daiichi Sankyo Inc. $832.5009/14/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930889101 CMS
E.R. Squibb & Sons, L.L.C. $212.9809/12/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932641677 CMS
E.R. Squibb & Sons, L.L.C. $233.0909/12/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932641679 CMS
Amgen Inc. $3,000.0009/07/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939873039 CMS
AstraZeneca Pharmaceuticals LP $4,450.0009/06/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914631947 CMS
AstraZeneca Pharmaceuticals LP $4,450.0009/06/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915004959 CMS
E.R. Squibb & Sons, L.L.C. $110.0009/06/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932641667 CMS
Amgen Inc. $310.0009/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939873041 CMS
AstraZeneca Pharmaceuticals LP $1,650.0009/01/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915399293 CMS
Amgen Inc. $104.6208/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939873037 CMS
ABBVIE INC. $2,750.0008/30/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893269345 CMS
E.R. Squibb & Sons, L.L.C. $3,665.0008/30/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932641665 CMS
ABBVIE INC. $21.6108/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893269343 CMS
Regeneron Healthcare Solutions, Inc. $7,655.0008/25/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927488935 CMS
E.R. Squibb & Sons, L.L.C. $4,205.0008/23/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932641725 CMS
AstraZeneca Pharmaceuticals LP $150.0008/22/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914884543 CMS
Karyopharm Therapeutics Inc. $4,075.0008/19/2022 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946524387 CMS
Karyopharm Therapeutics Inc. $110.0008/19/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 946524401 CMS
AstraZeneca Pharmaceuticals LP $0.7708/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914644087 CMS
AstraZeneca Pharmaceuticals LP $57.7608/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914700985 CMS
AstraZeneca Pharmaceuticals LP $1,040.0008/18/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915017639 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $264,541.35 325
PY2020 $220,023.17 253
PY2021 $482,263.59 368
PY2022 $495,492.09 406
PY2023 $428,531.95 359
PY2024 $282,331.25 272
PY2025 $291,443.81 226

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2020 Principal investigator $290.00 4
PY2019 Principal investigator $741.50 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme Corporation $100.00 11/24/2020 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with 1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy No dispute reported 06/30/2026 740831327
Principal investigator 1 Merck Sharp & Dohme Corporation $100.00 11/24/2020 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with 1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy No dispute reported 06/30/2026 740831329
Principal investigator 1 Merck Sharp & Dohme Corporation $30.00 07/29/2020 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with 1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy No dispute reported 06/30/2026 740830957
Principal investigator 1 Merck Sharp & Dohme Corporation $60.00 07/29/2020 Covered Recipient Teaching Hospital
CITY OF HOPE NATIONAL MEDICAL CTR
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of MK-3475 as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer with 1 cm Residual Invasive Cancer or Positive Lymph Nodes pN1mic After Neoadjuvant Chemotherapy No dispute reported 06/30/2026 740831877